MedPath

Investigation of a Novel Silicone Dressing to Maximize the Outcomes of Scar Revision Procedures (IMPROVE)

Not Applicable
Completed
Conditions
Hypertrophic
Interventions
Device: embrace device
Registration Number
NCT01430130
Lead Sponsor
Neodyne Biosciences, Inc.
Brief Summary

Neodyne has developed an investigational dressing for post-operative incision care. Neodyne is conducting this research to study whether the investigational dressing, called the Neodyne Dressing, can minimize scar formation in a simple manner.

Detailed Description

It is proposed to study a dressing designed to reduce the appearance of scars after scar revision surgery. It is expected that by managing the incision site after primary closure but during the longer term healing phase, scar formation may be minimized.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • The scar to be revised is:

    • at least 12 months old
    • linear and suitable for revision by excision and direct closure
    • appropriate size and location for Neodyne Dressing
  • The subject:

    • age > 18 and < 65 years old
Exclusion Criteria
  • Subjects with a skin disorder that is chronic or currently active.
  • Subjects who are involved in ongoing litigation in connection with the scar to be revised.
  • Subjects with a history of collagen vascular disease
  • Subjects diagnosed with scleroderma
  • Subject who currently smokes
  • Subjects with known adverse reactions to steri-strip tapes, medical tapes, or adhesives
  • Subjects with oozing, dehiscence, non-closed/healed incisions at time of first application.
  • Subjects with inability to maintain adequate care of incision.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
All Study Participantsembrace deviceHalf of the revised incision was treated with the embrace device. Half of the revised incision was treated according to the Investigator's standard of care. Participant served as his/her own control.
Primary Outcome Measures
NameTimeMethod
Visual Analogue Scale (VAS)6 months

Visual Analogue Scale Scar Score (VAS Scar Score) was defined and validated by Duncan et al 2006\[1\]. This scale consists of a 10cm line representing scar quality, with 0 representing normal skin and 10 indicating a poor scar. The assessor places a mark along the line to represent the appearance of the scar. This mark is translated into a score by measuring its position on the 10cm line to one decimal place. The independent panel used this to scale the primary outcome.

\[1\] Duncan J, Bond J, Mason T, Ludlow A, Cridland P, O'Kane S and Ferguson M. Visual Analogue Scale Scoring and Ranking: A Suitable and Sensitive Method for Assessing Scar Quality? Plast. Reconstr. Surg. 118: 909, 2006.

Secondary Outcome Measures
NameTimeMethod
Comparison of Scar Smoothness of Treated Side as Compared to the Control SideUp to 12 months
Subject and Investigator Satisfaction With the Aesthetic ResultsUp to 12 months
Ease of UseUp to 12 months
Comfort Level Related to Study Device Application, Wear and RemovalUp to 12 weeks

Trial Locations

Locations (1)

Duet Plastic Surgery

🇺🇸

Palo Alto, California, United States

© Copyright 2025. All Rights Reserved by MedPath